Quick Answer
Kodiak Sciences Inc. reported Cash and Equivalents of $209.86 million for fiscal year 2025.
Kodiak Sciences Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $209.86M | +24.9% |
| 2024 | $168.07M | -41.1% |
| 2023 | $285.51M | +49.9% |
| 2022 | $190.43M | -74.0% |
| 2021 | $731.51M | -22.5% |
| 2020 | $944.40M | +345.9% |
| 2019 | $211.80M | +140.0% |
| 2018 | $88.25M | +6226.5% |
| 2017 | $1.40M | -85.5% |
| 2016 | $9.62M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $72.04M | -63.6% | -30.8% |
| June 30, 2025 | $104.17M | -52.5% | -25.0% |
| March 31, 2025 | $138.85M | -43.5% | -17.4% |
| December 31, 2024 | $168.07M | -41.1% | -15.1% |
| September 30, 2024 | $197.86M | -42.8% | -9.7% |
| June 30, 2024 | $219.22M | -42.1% | -10.9% |
| March 31, 2024 | $245.92M | -22.3% | -13.9% |
| December 31, 2023 | $285.51M | +49.9% | -17.4% |
- Kodiak Sciences Inc. showed an increase of +24.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2016–2025 period, Kodiak Sciences Inc.’s cash and equivalents has grown by 2081.1% (from $9.62 million to $209.86 million).
- The most recent figure is from Kodiak Sciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: